Inventor · disambiguated record
Devon Shedlock
Also filed as: SHEDLOCK DEVON · SHEDLOCK DEVON J
18 granted patents·17 pending applications·76 citations·filing 2012–2024
93Inventor score
Top patents by PatentIndex Score
35 records- 0196US10513686B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·12 cites·30 claims
- 0295US11028143B2Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2015·Granted Jun 8, 2021·9 cites·16 claims
- 0395US10329543B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·14 cites·28 claims
- 0494US9597388B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameWEINER DAVID B·Filed 2013·Granted Mar 21, 2017·13 cites·14 claims
- 0593US11718656B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2022·Granted Aug 8, 2023·1 cites·10 claims
- 0689US10765733B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2018·Granted Sep 8, 2020·2 cites·25 claims
- 0789US10415016B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·3 cites·22 claims
- 0889US9243041B2Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereofWEINER DAVID B·Filed 2012·Granted Jan 26, 2016·12 cites·18 claims
- 0988US10034930B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2017·Granted Jul 31, 2018·5 cites·14 claims
- 1086US12358966B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 1186US11802269B2Superpiggybac transposase compositionsPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Oct 31, 2023·1 cites·5 claims
- 1286US11377480B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jul 5, 2022·2 cites·1 claims
- 1386US2024100143A1Filovirus Consensus Antigens, Nucleic Acid Constructs And Vaccines Made Therefrom, And Methods Of Using SameUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1486US2025296977A1Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1580US12415844B2BCMA specific VCAR compositions and methods for usePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 16, 2025·1 cites·79 claims
- 1676US2024318136A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1774US11723969B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2020·Granted Aug 15, 2023·0 cites·11 claims
- 1874US2024084251A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1972US12162922B2Enhanced antigen presenting ability of RNA car T cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2021·Granted Dec 10, 2024·0 cites·22 claims
- 2072US9994619B2Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Jun 12, 2018·1 cites·20 claims
- 2171US2024226153A9Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2263US2019119636A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2362US11744861B2Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 5, 2023·0 cites·19 claims
- 2455US2022042038A1Nanotransposon compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2555US2019233843A1Transposon system and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2654US2023079955A1Anti-muc1 compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2753US2022372105A1Allogeneic cell compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2851US12385061B2Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expressionPOSEIDA THERAPEUTICS INC·Filed 2018·Granted Aug 12, 2025·0 cites·14 claims
- 2951US2020063157A9Transposon system and methods of usePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3051US2022389077A1Allogeneic cell compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3147US2021107993A1Cartyrin compositions and methods for usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3245US2023121433A1Chimeric stimulatory receptors and methods of use in t cell activation and differentiationPOSEIDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3343US2021115453A1Transposon system and methods of usePOSEIDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3442US2019328784A1Chimeric antigen receptors (cars) specific for muc1 and methods for their usePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3541US2019177421A1Chimeric antigen receptors and methods for usePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Devon Shedlock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →